|Title:||South-East Asia Regional response framework for DR-TB, 2017-2021|
|Authors:||World Health Organization. Regional Office for South-East Asia|
|Publisher:||World Health Organization. Regional Office for South-East Asia|
|Place of publication:||New Delhi|
|Abstract:||The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from six countries of the SEA Region. MDR-TB could potentially replace drug-susceptible TB, and constitutes a threat to global public health security. In May 2014, the World Health Assembly adopted the End TB strategy. The End TB Strategy has as its vision a world free of TB, with zero deaths, disease and suffering due to TB. Ending TB is not possible without addressing the issues of MDR-TB. The South- East Asia Regional Response Framework for DR-TB 2017–2021 complements the Ending TB in the South-East Asia Region: Regional Strategic Plan 2016–2020” and outlines key strategies for reducing morbidity, mortality and transmission of DR-TB. By fully implementing this Response Framework, the Region will be on track for achieving the overall goal of ending TB. The Plan anticipates that by 2021, all Member States would have fully implemented the WHO guidelines on MDR-TB management and there will be universal access to quality-assured services for all those who need them.|
|License:||CC BY-NC-SA 3.0 IGO|
|Appears in Collections:||SEARO Publications|
Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.